As of 2025-02-19, the EV/EBITDA ratio of Repligen Corp (RGEN) is -114.56. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RGEN's latest enterprise value is 7,969.57 mil USD. RGEN's TTM EBITDA according to its financial statements is -69.56 mil USD. Dividing these 2 quantities gives us the above RGEN EV/EBITDA ratio.
Range | Selected | |
Trailing P/E multiples | 14.4x - 18.9x | 16.5x |
Forward P/E multiples | 19.4x - 24.1x | 21.7x |
Fair Price | (13.20) - 55.76 | 17.47 |
Upside | -109.0% - -62.0% | -88.1% |
Date | EV/EBITDA |
2025-02-14 | -114.56 |
2025-02-13 | -113.96 |
2025-02-12 | -113.60 |
2025-02-11 | -116.63 |
2025-02-10 | -120.15 |
2025-02-07 | -121.92 |
2025-02-06 | -126.60 |
2025-02-05 | -126.65 |
2025-02-04 | -125.12 |
2025-02-03 | -125.00 |
2025-01-31 | -130.10 |
2025-01-30 | -131.16 |
2025-01-29 | -132.67 |
2025-01-28 | -136.57 |
2025-01-27 | -131.55 |
2025-01-24 | -129.84 |
2025-01-23 | -131.46 |
2025-01-22 | -130.61 |
2025-01-21 | -131.48 |
2025-01-17 | -125.51 |
2025-01-16 | -127.40 |
2025-01-15 | -122.92 |
2025-01-14 | -122.32 |
2025-01-13 | -123.84 |
2025-01-10 | -120.96 |
2025-01-08 | -120.83 |
2025-01-07 | -119.86 |
2025-01-06 | -120.30 |
2025-01-03 | -116.96 |
2025-01-02 | -111.45 |
2024-12-31 | -112.16 |
2024-12-30 | -112.06 |
2024-12-27 | -113.45 |
2024-12-26 | -113.65 |
2024-12-24 | -114.59 |
2024-12-23 | -113.54 |
2024-12-20 | -112.58 |
2024-12-19 | -114.26 |
2024-12-18 | -114.90 |
2024-12-17 | -123.60 |
2024-12-16 | -125.84 |
2024-12-13 | -122.21 |
2024-12-12 | -121.87 |
2024-12-11 | -121.27 |
2024-12-10 | -118.61 |
2024-12-09 | -120.85 |
2024-12-06 | -116.40 |
2024-12-05 | -110.81 |
2024-12-04 | -116.31 |
2024-12-03 | -115.84 |